BIOM addresses one of Europe’s most devastating plant diseases caused by Xylella fastidiosa with and innovative and Endotherapeutic Bioformulation avoiding massive tree destruction and multi‑billion‑euro losses. The company also develops other biological technologies to improve performance, stability and efficiency of microbial-based agricultural solutions.